The principal objective of the study is to determine prospectively the relationship between breast cancer risk and measures of endocrine function, viz., serum measurements of estrogens (especially non-protein-bound estradiol), prolactin, and saliva measurements of progesterone. This study will have the advantage over most previous studies in that serum samples will be obtained before clinical disease is present and that multiple samples will be obtained. For premenopausal women serial saliva progesterones will be obtained over the full luteal phases of multiple menstrual cycles, to document possible luteal abnormalities. About 18,000 women between the ages of 35 and 64 from a breast cancer screening clinic in New York City will be enrolled in the study. Breast cancers will be ascertained as completely as possible (including """"""""interval"""""""" cases as well as those detected at screening), and pathology reports will be obtained to verify the diagnosis. Brief questionnaires on breast cancer risk factors and on hypothesized dietary promoters or inhibitors of breast cancer will also be given to all subjects. More extensive questionnaires on these factors will be administered on a case-control basis. Serum and saliva samples will be frozen and stored so that assays can be conducted in a case-control format. The blood- and saliva- progesterone assays, plus a record on onset of next menses, will permit interpretation of progesterone status. The multiple menstrual cycles assessed will provide a more accurate assessment of endocrine function than is available in most studies. It is anticipated that this study will provide the most definitive data available on the relationships among endocrine function, epidemiologic risk variables and breast cancer. It could also provide new leads for targeted breast-cancer screening or for preventive interventions. The availability of frozen serum specimens from a substantial number of breast cancer cases and controls will also make possible to assess additional hypotheses when new concepts and/or assays are originated; as such it represents a valuable resource for the future.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
2R01CA034588-04A1
Application #
3172307
Study Section
Epidemiology and Disease Control Subcommittee 3 (EDC)
Project Start
1984-07-01
Project End
1993-06-30
Budget Start
1988-07-01
Budget End
1989-06-30
Support Year
4
Fiscal Year
1988
Total Cost
Indirect Cost
Name
New York University
Department
Type
Schools of Medicine
DUNS #
004514360
City
New York
State
NY
Country
United States
Zip Code
10012
Wu, Chen; Kraft, Peter; Stolzenberg-Solomon, Rachael et al. (2014) Genome-wide association study of survival in patients with pancreatic adenocarcinoma. Gut 63:152-60
Klein, Alison P; Lindström, Sara; Mendelsohn, Julie B et al. (2013) An absolute risk model to identify individuals at elevated risk for pancreatic cancer in the general population. PLoS One 8:e72311
Jian, Jinlong; Yang, Qing; Shao, Yongzhao et al. (2013) A link between premenopausal iron deficiency and breast cancer malignancy. BMC Cancer 13:307
Jian, Jinlong; Yang, Qing; Huang, Xi (2011) Src regulates Tyr(20) phosphorylation of transferrin receptor-1 and potentiates breast cancer cell survival. J Biol Chem 286:35708-15
Jian, Jinlong; Yang, Qing; Dai, Jisen et al. (2011) Effects of iron deficiency and iron overload on angiogenesis and oxidative stress-a potential dual role for iron in breast cancer. Free Radic Biol Med 50:841-7
Wolpin, Brian M; Kraft, Peter; Gross, Myron et al. (2010) Pancreatic cancer risk and ABO blood group alleles: results from the pancreatic cancer cohort consortium. Cancer Res 70:1015-23
Arslan, Alan A; Helzlsouer, Kathy J; Kooperberg, Charles et al. (2010) Anthropometric measures, body mass index, and pancreatic cancer: a pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan). Arch Intern Med 170:791-802
Brooks, Jennifer D; Cairns, Paul; Shore, Roy E et al. (2010) DNA methylation in pre-diagnostic serum samples of breast cancer cases: results of a nested case-control study. Cancer Epidemiol 34:717-23
Arslan, Alan A; Shore, Roy E; Afanasyeva, Yelena et al. (2009) Circulating estrogen metabolites and risk for breast cancer in premenopausal women. Cancer Epidemiol Biomarkers Prev 18:2273-9
Jian, Jinlong; Pelle, Edward; Huang, Xi (2009) Iron and menopause: does increased iron affect the health of postmenopausal women? Antioxid Redox Signal 11:2939-43

Showing the most recent 10 out of 79 publications